About
Arcadia Science is a pioneering evolutionary biology company based in Emeryville, CA, that applies lessons from evolution — the world's largest natural R&D program — to modern drug development. The company's platform integrates evolutionary structure across the full research and development cycle, enabling more accurate prediction and testing of therapeutics. A flagship offering is Zoogle, an organismal search tool that leverages billions of years of evolutionary data to help researchers predict which organisms are the most relevant models for specific aspects of human biology. This enables smarter selection of research models and reduces reliance on potentially less-applicable species. Arcadia is deeply committed to open science, releasing apps, software pipelines, protocols, and research findings early and often to maximize scientific utility, rigor, and impact. Their tools are made freely available to the broader research community, lowering barriers to cutting-edge evolutionary and biological insights. The platform is aimed at drug developers, biomedical researchers, and scientists seeking data-driven approaches to model selection and therapeutic development. By grounding research in evolutionary biology, Arcadia Science helps teams make better-informed decisions earlier in the development pipeline — reducing wasted resources and improving the probability of therapeutic success.
Key Features
- Zoogle Organismal Search: A web portal that uses evolutionary data to predict which organisms are the most relevant models for specific aspects of human biology.
- Open Science Platform: Freely releases apps, software pipelines, protocols, and research resources to the broader scientific community for maximum impact.
- Evolutionary Drug Development Framework: Applies evolutionary biology principles across the full R&D cycle to improve therapeutic prediction and testing accuracy.
- Early Research Publication: Publishes research early and often to improve scientific rigor and foster collaboration across institutions.
Use Cases
- Identifying the most biologically relevant organism models for human disease research using Zoogle's evolutionary search capabilities.
- Accelerating early-stage drug discovery by applying evolutionary biology frameworks to narrow down therapeutic candidates.
- Accessing open-source bioinformatics pipelines and protocols for reproducible research in evolutionary and biomedical science.
- Informing model organism selection in preclinical studies to improve translational success rates.
- Staying current with open-access publications and tools from a cutting-edge evolutionary biology research organization.
Pros
- Open and Freely Available Tools: All platform tools and research are released openly to the scientific community at no cost, encouraging broad adoption and collaboration.
- Novel Evolutionary Approach: Unique use of evolutionary biology as a framework for drug development provides insights not available through traditional biomedical methods.
- Rigorous Scientific Standards: Strong commitment to reproducibility and open publication ensures high-quality, trustworthy research outputs.
Cons
- Highly Specialized Audience: Tools and platform are designed for biomedical researchers and drug developers, limiting accessibility for general users.
- Early-Stage Platform: As an emerging company, some platform components are still under active development and may not yet be fully mature.
Frequently Asked Questions
Arcadia Science is an evolutionary biology company that uses lessons from evolution to improve how therapeutics are predicted and tested during drug development.
Zoogle is an organismal search tool developed by Arcadia Science that leverages billions of years of evolutionary data to help researchers identify the most relevant organism models for different aspects of human biology.
Yes. Arcadia Science is committed to open science and releases its apps, software pipelines, protocols, and research resources freely to the scientific community.
The platform is primarily designed for biomedical researchers, drug developers, and scientists interested in using evolutionary biology to guide therapeutic research and model selection.
Unlike traditional drug development, Arcadia Science uses the structural patterns of evolution to inform research decisions, helping teams better predict which therapeutics will be effective and which organism models are most applicable to human disease.